Stocks
Health Care
nby
Novabay Pharmaceuticals
NYSE MKT LLC: NBY
+9.77 (+103.28%)
19.23
USD
At close at Jan 09, 21:38 UTC
Income Statement
Revenue
7.15M
Gross Profit
4.69M
Operating Income
-5.84M
Pretax Income
-7.21M
Net Income
-7.22M
EBITDA
-6.76M
EBIT
-7.22M
Earnings Per Share
-30.48
Balance Sheet
Cash & Cash Equivalents
945.00K
Total Debt
1.84M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
121.50K
Book Value Per Share
0.04
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.